| Company Name: |
Biolab Reagents |
| Tel: |
027-65279366 18108604356 |
| Email: |
products@biolabreagent.com |
|
| | Bezlotoxumab Basic information |
| Product Name: | Bezlotoxumab | | Synonyms: | Bezlotoxumab;Research Grade Bezlotoxumab (DXX00301);Research Grade Bezlotoxumab | | CAS: | 1246264-45-8 | | MF: | | | MW: | 0 | | EINECS: | | | Product Categories: | | | Mol File: | Mol File | ![Bezlotoxumab Structure]() |
| | Bezlotoxumab Chemical Properties |
| form | Liquid | | color | Colorless to light yellow |
| | Bezlotoxumab Usage And Synthesis |
| Uses | Bezlotoxumab is a human monoclonal antibody directed against C. difficile toxin B. Bezlotoxumab binds to C. difficile toxin B preventing intestinal epithelial damage and colitis[1]. | | Clinical Use | Human monoclonal antitoxin antibody:
Prevention of recurrence of Clostridium difficile
infection | | Metabolism | Bezlotoxumab is catabolized through protein degradation
processes; metabolism does not contribute to its clearance.
It is eliminated from the body primarily by protein
degradation. | | References | [1] Navalkele BD, et, al. Bezlotoxumab: an emerging monoclonal antibody therapy for prevention of recurrent Clostridium difficile infection. Biologics. 2018 Jan 18;12:11-21. DOI:10.2147/BTT.S127099 |
| | Bezlotoxumab Preparation Products And Raw materials |
|